Methadone is the oldest approved medication for treating opioid use disorder (OUD) and, for many patients, it is the optimal treatment for managing symptoms and reducing overdose risk.1 Methadone has been dispensed exclusively through highly regulated opioid treatment programs (OTPs), which operate in fixed locations since it was authorized for OUD 50 years ago.1 A legacy of this regulated system is a lack of treatment access.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gibbons JB, Stuart EA, Saloner B. Methadone on Wheels—A New Option to Expand Access to Care Through Mobile Units. JAMA Psychiatry. 2022;79(3):187–188. doi:10.1001/jamapsychiatry.2021.3716
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.